Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

34
Number of overlapping holdings
15.2%
% of IBB's 260 holdings also in GNOM
87.2%
% of GNOM's 39 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in GNOM |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 3.5% | 4.5% | 3.5% | |
GILEAD SCIENCES INC | 8.6% | 3.4% | 3.4% | |
VERTEX PHARMACEUTICALS INC | 9.6% | 3.0% | 3.0% | |
NATERA INC | 2.3% | 7.1% | 2.3% | |
BIONTECH SE SPONSORED ADR | 2.0% | 5.1% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to GNOM
AMGEN INC | 8.4% | |
REGENERON PHARMACEUTICALS | 7.2% | |
VERTEX PHARMACEUTICALS INC | 6.6% | |
GILEAD SCIENCES INC | 5.2% | |
ARGENX SE ADR | 3.1% | |
IQVIA HOLDINGS INC | 3.1% | |
METTLER-TOLEDO INTERNATIONAL | 2.5% | |
WATERS CORP | 2.3% | |
BIOGEN IDEC INC | 2.1% | |
INSMED INC | 1.6% |
IBB Underweight Relative to GNOM
VERACYTE INC | -5.2% | |
NATERA INC | -4.8% | |
AGILENT TECHNOLOGIES INC | -4.4% | |
CRISPR THERAPEUTICS AG | -4.3% | |
GENSCRIPT BIOTECH CORPORATION | -3.8% | |
LEGEND BIOTECH CORPORATION SPONSORED | -3.7% | |
BIOMARIN PHARMACEUTICAL INC | -3.4% | |
ULTRAGENYX PHARMACEUTICAL IN | -3.3% | |
BIONTECH SE SPONSORED ADR | -3.1% | |
BEAM THERAPEUTICS, INC. | -3.1% |